It confirmed my previous comments regarding the PANAX facility having both indoor and outdoor cultivation space and, it gave me something new to research and be excited about.
With the Panax acquisition nearing completion, the Company is now exploring opportunities for out-licensing its extensive genetics, breeding and growing know-how and has commenced early stage discussion with potential North American operators.
This would strategically complement the Company’s newly signed MGC Derma products exclusive distribution agreement with Californian-based company C&M CBD HOLDING LLC for
cosmetics containing CBD extracts produced within the US, and facilitate a US base for expansion of the MGC Derma business and operations.
MXC Price at posting:
5.3¢ Sentiment: Buy Disclosure: Held
